Clinical trial

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

NCT01786265

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Abiraterone Acetate Normalized identity: abiraterone acetateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Bicalutamide Normalized identity: bicalutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Degarelix Normalized identity: degarelixView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Flutamide Normalized identity: flutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Goserelin Acetate Normalized identity: goserelin acetateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Leuprolide Acetate Normalized identity: leuprolide acetateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Nilutamide Normalized identity: nilutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Prednisone Normalized identity: prednisoneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2013-02-05

PhasePHASE2

Conditions

Prostate Adenocarcinomaverified · MONDO: prostate adenocarcinoma

Recurrent Prostate Carcinomaunresolved

Interventions

Abiraterone AcetateDRUG · verified · RxNorm: abiraterone acetate

BicalutamideDRUG · verified · RxNorm: bicalutamide

DegarelixDRUG · verified · RxNorm: degarelix

FlutamideDRUG · verified · RxNorm: flutamide

Goserelin AcetateDRUG · verified · RxNorm: goserelin acetate

Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate

NilutamideDRUG · verified · RxNorm: nilutamide

PrednisoneDRUG · verified · RxNorm: prednisone

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01786265 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.